News

The paper, ‘A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia,’ published in the Journal of Antimicrobial Chemotherapy, provides an overview of the treatment of a single

The platform’s Protein Chain Reaction allows for screening against cell surface targets in their native state on live cells or purified target proteins. X-BODY claims that its platform

Aricept (donepezil HCl) is a prescription medicine to treat mild, moderate and severe alzheimer’s disease. Ranbaxy Pharmaceuticals Trade Sales vice president Bill Winter said that they are pleased

Icagen and Pfizer have recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7. They have now selected one of

According to the studies in preclinical models of alzheimer’s disease, ELND005 is believed to inhibit the aggregation (clumping) of amyloid-beta proteins in the brain thereby neutralising the toxic

The CellCiphr cytotoxicity panels detect toxicological markers in a range of cell models (HepG2, primary hepatocytes and cardiomyocytes). The CellCiphr technology applies High Content Screening (HCS) technology to

Frazier will succeed Richard Clark, who has served as Merck’s CEO since 2005 and will continue as chairman of the board. Merck said that Frazier has served as

StayinFront claims that EdgeRx delivers fully featured on-demand CRM and integrated analytics capabilities, while offering the flexibility to access the system online or offline. StayinFront EdgeRx includes everything

HCL Technologies will be responsible for transforming Purdue‘s IT environment by implementing its processes as per ITIL V3 and MTaaS platform, which is HCL’s business-ready hosted platform for